TABLE 1.
Clinical characteristics of esophageal carcinoma (ESCA) patients.
| Characteristic | Low expression of APOC1 | High expression of APOC1 | p |
|---|---|---|---|
| N | 81 | 81 | |
| Age, n (%) | 0.346 | ||
| <=60 | 45 (27.8%) | 38 (23.5%) | |
| >60 | 36 (22.2%) | 43 (26.5%) | |
| Gender, n (%) | 0.177 | ||
| Female | 15 (9.3%) | 8 (4.9%) | |
| Male | 66 (40.7%) | 73 (45.1%) | |
| Tumor central location, n (%) | 0.168 | ||
| Distal | 55 (34.2%) | 58 (36%) | |
| Mid | 24 (14.9%) | 18 (11.2%) | |
| Proximal | 1 (0.6%) | 5 (3.1%) | |
| T stage, n (%) | 0.012 | ||
| T1 | 18 (12.4%) | 9 (6.2%) | |
| T2 | 21 (14.5%) | 16 (11%) | |
| T3 | 31 (21.4%) | 46 (31.7%) | |
| T4 | 0 (0%) | 4 (2.8%) | |
| N stage, n (%) | 0.424 | ||
| N0 | 37 (25.7%) | 29 (20.1%) | |
| N1 | 29 (20.1%) | 34 (23.6%) | |
| N2 | 3 (2.1%) | 6 (4.2%) | |
| N3 | 2 (1.4%) | 4 (2.8%) | |
| M stage, n (%) | 1.000 | ||
| M0 | 57 (44.2%) | 64 (49.6%) | |
| M1 | 4 (3.1%) | 4 (3.1%) | |
| Histological type, n (%) | 0.157 | ||
| Adenocarcinoma | 35 (21.6%) | 45 (27.8%) | |
| Squamous Cell Carcinoma | 46 (28.4%) | 36 (22.2%) | |
| Pathologic stage, n (%) | 0.005 | ||
| Stage I | 13 (9.2%) | 3 (2.1%) | |
| Stage II | 36 (25.4%) | 33 (23.2%) | |
| Stage III | 16 (11.3%) | 33 (23.2%) | |
| Stage IV | 4 (2.8%) | 4 (2.8%) | |
| BMI, n (%) | 0.040 | ||
| <=25 | 36 (23.5%) | 48 (31.4%) | |
| >25 | 42 (27.5%) | 27 (17.6%) | |
| Reflux history, n (%) | 0.967 | ||
| No | 42 (30.9%) | 42 (30.9%) | |
| Yes | 25 (18.4%) | 27 (19.9%) | |
| Barrett’s esophagus, n (%) | 0.511 | ||
| No | 51 (38.6%) | 55 (41.7%) | |
| Yes | 15 (11.4%) | 11 (8.3%) | |
| Alcohol history, n (%) | 0.635 | ||
| No | 21 (13.2%) | 25 (15.7%) | |
| Yes | 58 (36.5%) | 55 (34.6%) | |
| Age, mean ± SD | 61.32 ± 11.84 | 63.16 ± 12.2 | 0.332 |
| BMI, median (IQR) | 25.49 (22.12, 28.73) | 23.74 (20.87, 26.61) | 0.027 |